Product at https://xitter.cf/t.co/KcmF7JH6Wf. Previous career statistical researcher in clinical trial design and analysis. All views my own. She/her.
Joined June 2018
- Tweets310
- Following311
- Followers171
- Likes1.6K
Alyssa Vanderbeek retweeted
Exciting fully-funded PhD opportunity @ICR_London in methods research in early phase clinical trials, starting from October 2024. The successful candidate will join an amazing @MRCTMRPDTP community of methodologists and innovators! Please share! rb.gy/1dax88 @ICR_CTSU
Come and join us! We are recruiting a fully funded PhD student to our @MRCTMRPDTP with @ChristinaBYap at ICR. Please share widely. Closing date 15 August. For more information see mrctmrpdtp.com/current-oppor…
ALT An image advertising a fully funded PhD project entitled design and analysis of early phase adaptive platform trials in the era of precision oncology. Based at the Institute of ICR. Closing date 15 August 2024. Project start date is October 2024 or soon thereafter.
Google Docs including suggestions in its word count feature has to be universally unacceptable. Right?
Could... could it be that we're one step closer to the dream of using NLP to scrape protocols? ema.europa.eu/en/ich-m11-gui…
I’ll be at Unlearn AI’s booth at #JSM2022 from 10:30-2 today. Stop by to chat and learn more about our mission and current opportunities! Or be sure to visit my colleagues tmrw and Wednesday 9-5 jobs.lever.co/UnlearnAI
Alyssa Vanderbeek retweeted
Join us at JSM 2022, 08/06-08/11 in Washington, DC. As an event sponsor, take a photo at the photobooth and visit the Unlearn team at booth #209. @amstatnews
Come be my Director and oversee the cool methodologies we’re working on! Hiring for other roles in research and applied biostats, machine learning, and others
Unlearn is hiring for a Head of Biostatistics Research and will be reviewing applications and scheduling interviews during JSM 2022. All registered applicants can apply through the JSM Career Portal, here: bit.ly/3RFitB0 @Amstatnews
Alyssa Vanderbeek retweeted
Welcome to America, where we care so much about life that the guns of boys and men proliferate while girls, women, and other pregnant people routinely die for lack of access to abortion
Alyssa Vanderbeek retweeted
You don’t often hear about companies seeking more regulatory oversight. The technology used in clinical trials doesn’t need regulatory approval. #Startup @UnlearnAI sought a review of its #AI tech anyway, and it’s now reaping rewards from the result... medcitynews.com/2022/04/ai-s…
Alyssa Vanderbeek retweeted
Unlearn is excited to announce that we have closed a $50 million Series B funding round, led by @insightpartners with participation from new investor @radicalvcfund and existing investors @8VC, @DCVC, @DCVCBio, and @Mubadala. #machinelearning bwnews.pr/3vor9RY
My first publication (2018) has surpassed 50 citations! This was an exciting systematic review, where I also derived a procedure to estimate the % of patients enrolled in #Glioblastoma trials academic.oup.com/neuro-oncol…
FDA released their final guidance document for master protocols in oncology today. “Platform trial” remains in-explicitly defined — I’m curious about responses to this in academia fda.gov/regulatory-informati…
Alyssa Vanderbeek retweeted
Surge in use of efficient platform trial design in #COVID19 #clinicaltrials (far exceeding historical use), with many adding new treatment arms rapidly.
Joint work @VanderbeekAM @JudithBliss15 and Z.Yin @ICR_CTSU
sciencedirect.com/science/ar…
Alyssa Vanderbeek retweeted
New Employee Spotlight: Meet @UnlearnAI's Research Biostatistician, @VanderbeekAM! Alyssa is an accomplished biostatistician who will be developing new methods for utilizing #DigitalTwins in clinical trial design. #AI #Hiring #WeAreHiring bit.ly/3s5Llbj
We're live! doi.org/10.1016/j.cct.2021.1…
Happy to announce that my latest work, “Implementation of platform trials in the COVID-19 pandemic: a rapid review”, has been accepted for publication in Contemporary Clinical Trials. (To be shared when available!) 1/6
Huge thank yous to my advisor @ChristinaYap for her support and guidance on this project, and to my co-authors Zhulin Yin and @JudithBliss15 for their contributions!